Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-048429

Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 20,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2024-04-15 Option exercise +20,834 150,185 D
Vogt Frederick G Interim CEO & General Counsel 2024-04-15 Shares withheld for taxes −8,851 $11.89 $105,238 141,334 D
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2024-04-15 Option exercise · Restricted Stock Units −20,834 62,504 D
Loading xslF345X05/tm2412101-3_4seq1.xml…